Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Terbium-161 might be superior to lutetium-177 for oligometastases.

The Lancet. Oncology·2026
Same author

Prospective study on the [<sup>18</sup>F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

European journal of nuclear medicine and molecular imaging·2026
Same author

Prognostic impact of Dmax on baseline FDG-PET/CT in newly diagnosed multiple myeloma.

Haematologica·2026
Same author

Maturity Onset Diabetes of the Young (MODY): French National Diagnosis and Care Protocol (PNDS, Protocole National de Diagnostic et de Soins).

Orphanet journal of rare diseases·2026
Same author

[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

The Lancet. Oncology·2026
Same author

Prospective head-to-head comparison of [<sup>68</sup>Ga]Ga-RM2 PET/CT and [<sup>68</sup>Ga]Ga-PSMA-617 PET/CT in newly diagnosed patients with intermediate-risk localized prostate cancer.

European journal of nuclear medicine and molecular imaging·2026

相关实验视频

Updated: May 10, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

14.5K

第15章:复发性或持久性原发性甲状腺功能过高症,副甲状腺炎症.

Miriam Ladsous1, Sophie Deguelte2, Elif Hindié3

  • 1Endocrinology, Diabetology, Metabolism and Nutrition Department, CHU de Lille, hôpital Claude-Huriez, 59000 Lille, France.

Annales d'endocrinologie
|January 16, 2025
PubMed
概括

持续的原发性副甲状腺功能障碍症,定义为副甲状腺手术后6个月内高血症,需要仔细诊断. 排除其他疾病和专家手术重新评估对于成功管理至关重要.

关键词:
多腺体原发性甲状腺功能过强症.副氧化的发生持续的原发性副甲状腺功能障碍症.经常出现的原发性甲状腺功能增强症.

更多相关视频

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

3.3K
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

1.8K

相关实验视频

Last Updated: May 10, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

14.5K
Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

3.3K
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

1.8K

科学领域:

  • 内分泌学 在内分泌学.
  • 手术瘤学手术瘤学
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 持续性原发性甲状腺功能障碍是甲状腺功能障碍手术后6个月内出现的高血症.
  • 复发性原发性甲状腺功能增强症发生在最初治愈性甲状腺功能切除术后的6个月以上.
  • 差异性诊断包括二次性副甲状腺功能障碍症和家族性低血性高血症.

研究的目的:

  • 概述了持续性或复发性原发性甲状腺功能增强症的诊断和管理策略.
  • 强调准确的手术前评估和修复手术多学科团队讨论的重要性.
  • 突出专家中心和先进监测在成功重新运行的关键作用.

主要方法:

  • 对持续性和复发性副甲状腺功能障碍症的诊断标准的审查.
  • 强调形态和功能成像用于术前评估.
  • 讨论修复手术和多学科团队评估的指示.

主要成果:

  • 不完整的腺体切除是非专家中心中最常见的原因.
  • 对多腺体疾病的基因检测和对甲状腺癌等罕见病因的查是必不可少的.
  • 有效的成像和专业的外科手术技术改善了结果.

结论:

  • 修复副甲状腺手术需要彻底的手术前评估和多学科评估.
  • 对于更高风险的审查程序,建议使用具有手术内PTH测量和神经监测的专家中心.
  • 准确的诊断和量身定制的手术方法对于管理持久性或复发性甲状腺功能障碍症至关重要.